Bifidobacterium longum W11
Bifidobacterium longum W11 is a strain notable for its rifaximin resistance and has been studied primarily in the context of gastrointestinal health, particularly constipation and irritable bowel syndrome. In vitro research has examined a genetic factor governing the breakdown of arabinan, a plant-derived fiber. Observational clinical work has examined IBS constipation-variant symptoms in the context of administration alongside synbiotic formulations or antibiotics. The evidence base for W11 is largely observational and mechanistic rather than from large randomized trials. Strain-specific data is still maturing; W11 should not be viewed as a treatment for any gastrointestinal disease. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.
Where it's been studied Tags come from a conservative keyword scan of each paper's title, abstract, and summary. A tag is research coverage, not measured effect. How we classify this →
Share of this strain's 15 body-system-tagged papers that concern each system. Research coverage, not measured effect.
Symptoms in the research A tag means the paper's text names the symptom or condition — research coverage, not evidence of benefit. How we classify this →
Share of this strain's 10 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.
Research Study-type filters use AI-classified labels, audited but not guaranteed — check the paper itself before leaning on one. How we classify this →
16 papers reference this strain in the probiotic database.
Discussion
Be the first to comment.
Sign in to join the discussion.
Citations
Selected papers that name this strain.
-
[1]
Source →A SYSTEMATIC MAPPING REVIEW OF IN-VITRO AND IN-VIVO EVIDENCES EXPLORING THE ROLE OF STRAIN-SPECIFIC PROBIOTIC BIFIDOBACTERIUM LONGUM W11· International Journal of Pharmaceutical Sciences and Drug Research · 2024
-
[2]
PMID 17956582 →Differential immunomodulatory properties of Bifidobacterium logum strains: relevance to probiotic selection and clinical applications· Clinical & Experimental Immunology · 2007
-
[3]
PMID 17108864 →Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Results of an open, uncontrolled multicenter study.· PubMed · 2006